Sirtuins in macrophage immune metabolism: A novel target for cardiovascular disorders
Chen-Qin Xu,Ji Li,Zhi-Qiang Liang,Yi-Lang Zhong,Zhi-Hui Zhang,Xue-Qing Hu,Yong-Bing Cao,Jian Chen,Chen-qin Xu,Zhi-qiang Liang,Yi-lang Zhong,Zhi-hui Zhang,Xue-qing Hu,Yong-bing Cao
DOI: https://doi.org/10.1016/j.ijbiomac.2023.128270
IF: 8.2
2023-11-30
International Journal of Biological Macromolecules
Abstract:Sirtuins (SIRT1-SIRT7), as a family of NAD + -dependent protein modifying enzymes, have various catalytic functions, such as deacetylases, dealkalylases, and deribonucleases. The Sirtuins family is directly or indirectly involved in pathophysiological processes such as glucolipid metabolism, oxidative stress, DNA repair and inflammatory response through various pathways and assumes an important role in several cardiovascular diseases such as atherosclerosis, myocardial infarction, hypertension and heart failure. A growing number of studies supports that metabolic and bioenergetic reprogramming directs the sequential process of inflammation. Failure of homeostatic restoration leads to many inflammatory diseases, and that macrophages are the central cells involving the inflammatory response and are the main source of inflammatory cytokines . Regulation of cellular metabolism has emerged as a fundamental process controlling macrophage function, but its exact signaling mechanisms remain to be revealed. Understanding the precise molecular basis of metabolic control of macrophage inflammatory processes may provide new approaches for targeting immune metabolism and inflammation. Here, we provide an update of studies in cardiovascular disease on the function and role of sirtuins in macrophage inflammation and metabolism, as well as drug candidates that may interfere with sirtuins, pointing to future prospects in this field.
polymer science,biochemistry & molecular biology,chemistry, applied